Senior insider sale
AXSOME THERAPEUTICS, INC. — senior position signals high conviction
$141.7K
572.00 shares
What this filing means
JEFFS ROGER plans to sell 572.00 shares of AXSOME THERAPEUTICS, INC. valued at approximately $141.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/11/2026ACC: 0001921094-26-000636
572.00
Shares to sell
$141.7K
Approx. market value
286.00
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Lapse
Equity Compensation
6/6/2026
286.00Total acquired286.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/6/2026 | Restricted Stock Lapse Equity Compensation | 286.00 | — |
| Total | 286.00 | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
286.00
Market value
$70.4K
6/10/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
286.00
Market value
$71.2K
6/11/2026
Total
Units
572.00
Value
$141.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/10/2026 | 286.00 | $70.4K | — | Completed |
| Planned — Approximate Date | ||||
6/11/2026 | 286.00 | $71.2K | NASDAQ | Planned |
| Total | 572.00 | $141.7K | ||